Quick Answer
Neuronetics, Inc. reported Diluted EPS of $0.59 per share (loss) for fiscal year 2025.
Neuronetics, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.59 | +57.2% |
| 2024 | -$1.38 | -31.4% |
| 2023 | -$1.05 | +23.9% |
| 2022 | -$1.38 | -13.1% |
| 2021 | -$1.22 | +16.4% |
| 2020 | -$1.46 | +7.6% |
| 2019 | -$1.58 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.13 | +70.5% | +13.3% |
| June 30, 2025 | -$0.15 | +54.5% | +28.6% |
| March 31, 2025 | -$0.21 | +22.2% | +52.3% |
| September 30, 2024 | -$0.44 | -33.3% | -33.3% |
| June 30, 2024 | -$0.33 | -94.1% | -22.2% |
| March 31, 2024 | -$0.27 | +28.9% | +18.2% |
| September 30, 2023 | -$0.33 | -17.9% | -94.1% |
| June 30, 2023 | -$0.17 | +56.4% | +55.3% |
- Neuronetics, Inc. showed an increase of +57.2% in Diluted EPS compared to the prior fiscal year.
- Over the 2019–2025 period, Neuronetics, Inc.’s diluted eps has grown by 62.7% (from $1.58 per share (loss) to $0.59 per share (loss)).
- The most recent figure is from Neuronetics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: